top of page
Search Results

178 items found for "G protein-coupled receptors"

  • Ep 156 with Dr. Justin English

    developing and innovating technologies to solve broad questions in pharmacology, with a specific focus on G-protein coupled receptor signaling and biology."

  • GPCR Retreat 2023 - Part II

    protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration Sakmar’s laboratory at The Rockefeller University, where she study’s the signaling and degradation of G protein-coupled receptors. understand the signaling and degradation of GPCRs in disease states to help test the feasibility of using protein-targeted to understand the mechanism by which a new class of biased allosteric modulators for the neurotensin receptor

  • Ep 49 with Dr. Sudha Shenoy

    Shenoy’s postdoctoral research discovered that ubiquitination of mammalian G protein-coupled receptors is a tag for lysosomal degradation, whereas ubiquitination of the adaptor protein, β-arrestin, is a tag for receptor internalization and formation of signaling endosomes.

  • LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration

    protein-coupled receptor heteromerization is believed to exert dynamic regulatory impact on signal transduction CXC chemokine receptor 4 (CXCR4) and its ligand CXCL12, both of which are overexpressed in many cancers Likewise, lysophosphatidic acid receptor 1 (LPA1) is implicated in cancer cell proliferation and migration 4 , Chemotaxis , G protein-coupled receptor , GPCR heteromer , GPCR signaling , Inflammatory disease , Lysophosphatidic acid receptor 1 Source Contribute to the GPCR News Coming soon Become a Contributor

  • Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer

    GPCR News < GPCRs in Oncology and Immunology Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer Published date April 25, 2023 Abstract " Activation of heterotrimeric G-proteins (Gαβγ) by G-protein-coupled receptors (GPCRs) is a quintessential mechanism of cell signaling widely However, it has become evident that heterotrimeric G-proteins can also be activated via GPCR-independent Tags G protein , GPCR , cancer , drug discovery .

  • Ep 155 with Endocrine Metabolic GPCR Organizers

    Francisco with Professor Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling. cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor continued to undertake postdoctoral research in Oxford, investigating the signalling and trafficking of the G protein-coupled receptor (GPCR), calcium-sensing receptor, and its role in calcium homeostasis.

  • Ep 99 with Yamina Berchihce

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the

  • Ep 120 with Brendan Wilkins

    research assistant at the Victor Chang Cardiac Research Institute where he investigated the orphan G protein-coupled receptor (GPCR), GPR37L1. Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor

  • Ep 79 with Dr. Graeme Milligan

    His main research group centers on the function, structure, and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. into the selection of targets, screening, and identification of small molecule regulators of these proteins

  • Ep 157 with Dr. Nagarajan Vaidehi

    Following her postdoctoral studies on protein dynamics simulation methods at University of Southern California contributions in developing constrained molecular dynamics simulation methods with emphasis on application to G-protein coupled receptors and drug design."

  • Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma

    Thomas Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation of G protein-coupled receptors. understand the signaling and degradation of GPCRs in disease states to help test the feasibility of using protein-targeted

  • Gallein, G protein βγ subunits inhibitor, suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun N-terminal kinase

    < GPCR News < GPCRs in Oncology and Immunology Gallein, G protein βγ subunits inhibitor, suppresses the protein-coupled receptor (GPCR) signaling regulates a wide range of pathophysiological cell functions via G protein α and βγ subunits. TGF-α-stimulated phosphorylation of JNK without affecting the phosphorylation of epidermal growth factor receptor , AKT, p38 MAPK, target protein of Rho-kinase and STAT3.

  • The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy

    chemokine and metabolite GPCRs in personalized cancer therapy Published date September 12, 2024 Abstract "G protein-coupled receptors (GPCRs) are vital cell surface receptors that govern a myriad of physiological

  • Ep 73 with Dr. Aylin Hanyaloglu

    Francisco with Professor Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor trafficking and signaling. cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor

  • Illuminating Functional Selectivity and Allosterism at GPCRs.

    molecular pharmacology and his research program focuses on the molecular and cellular mechanisms regulating G protein-coupled receptor (GPCR) responses, a class of receptors involved in many, if not all, physiological He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor

  • GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting

    the nematode-trapping fungus, Arthrobotrys flagrans, that both are achieved through a dual-function G-protein-coupled receptor (GPCR). revealed that ascarosides activate the fungal GPCR, GprC, at the plasma membrane and together with the G-protein This dual localization of GprC in A. flagrans resembles the localization of the cannabinoid receptor share ascaroside-binding sites with the fungal GprC receptor, suggesting 400-million-year convergent

  • Ep 63 with Dr. Khaled Abdelrahman

    Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration

  • Ep 85 with Nicholas Holliday

    University of Nottingham in 2006, where he is now Associate Professor, establishing a lab focused on G protein-coupled receptor kinetics, signaling, and trafficking and on using novel imaging techniques,

  • Ep 18 with Dr. Yamina Berchiche

    G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide for quantitative, and multi‐scale integration of these amounts of data to gain novel insights into receptor How can we best leverage these exciting new techniques in areas such as protein structure prediction,

  • Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Protein-coupled receptors (GPCRs) are common drug targets, yet no approved drugs exist for the Adhesion G Protein-coupled receptors (aGPCRs or ADGRs). The NRS fuses the extracellular region of any given aGPCR with a cleavage module from a Notch receptor receptor 2 (PAR2). protein-coupled receptors (GPCRs), with a particular focus on the adhesion GPCRs (aGPCRs) family.

  • Role and recent progress of P2Y12 receptor in cancer development

    < GPCR News < GPCRs in Oncology and Immunology Role and recent progress of P2Y12 receptor in cancer development Published date June 14, 2024 Abstract "P2Y12 receptor (P2Y12R) is an adenosine-activated G protein-coupled receptor (GPCR) that plays a central role in platelet function, hemostasis, and thrombosis.

  • Ep 33 with Dr. David E. Gloriam

    Gloriam About this episode David Gloriam is a Professor in Computational Receptor Biology at the University protein-coupled receptors. He later identified physiological hormones of such under characterized ‘orphan’ receptors and functional probes for a range of receptors. Gloriam on the web LinkedIn ResearchGate Twitter Google Scholar Computation Receptor Biology- Gloriam

  • Ep 56 with Dr. Adriano Marchese

    Philadelphia, PA, for his postdoctoral training in Jeff Benovic’s laboratory studying the regulation of G protein-coupled receptor trafficking and signaling.

  • A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice

    Sponsors GPCR Retreat Program < Back to schedule A positive Allosteric Modulator of M1 Acetylcholine Receptors Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically to slow neurodegeneration

  • Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers

    in inflammatory diseases and cancers Published date March 15, 2023 Abstract " C-X-C motif chemokine receptor 2 (CXCR2) is G protein-coupled receptor (GPCR) and plays important roles in various inflammatory diseases Hence, we provide an overview containing the discovery history, protein structure, signaling pathways

  • C5aR2 receptor: The genomic twin of the flamboyant C5aR1

    < GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that tailors immune cell activity potentially through β-arrestins rather than G-proteins. dynamics; protein-protein interactions.

  • Noval insights and therapeutic strategies for tumor-induced kidney pathologies

    Xu et al. identified the mammalian neurokinin 3 receptor (TACR3), a homolog of the G protein-coupled receptor TkR99D in fruit flies, as a potential therapeutic target for alleviating renal tubular dysfunction

  • Unveiling Non-Canonical Functions for Gαq Signaling Pathways

    In her postdoctoral period, she has participated in the identification and characterization of proteins that act at the level of G proteins and which are part of a multimolecular signaling complex (AGS, de “Activators of G-protein signaling). Ribas' group has described a new interaction region in a cellular protein that has turned out to be very Ribas has also described a new protective role of G protein-coupled receptor kinase 2 (GRK2), a known

bottom of page